Tower Research Capital (TRC)’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-9,407
| Closed | -$16K | – | 7061 |
|
2022
Q1 | $16K | Buy |
9,407
+5,065
| +117% | +$8.62K | ﹤0.01% | 3786 |
|
2021
Q4 | $10K | Buy |
4,342
+2,576
| +146% | +$5.93K | ﹤0.01% | 4658 |
|
2021
Q3 | $10K | Sell |
1,766
-2,249
| -56% | -$12.7K | ﹤0.01% | 4390 |
|
2021
Q2 | $30K | Sell |
4,015
-2,297
| -36% | -$17.2K | ﹤0.01% | 3507 |
|
2021
Q1 | $51K | Sell |
6,312
-3,759
| -37% | -$30.4K | ﹤0.01% | 3117 |
|
2020
Q4 | $92K | Sell |
10,071
-1,558
| -13% | -$14.2K | ﹤0.01% | 2431 |
|
2020
Q3 | $129K | Buy |
11,629
+9,068
| +354% | +$101K | ﹤0.01% | 2940 |
|
2020
Q2 | $19K | Buy |
+2,561
| New | +$19K | ﹤0.01% | 3718 |
|
2020
Q1 | – | Sell |
-8,772
| Closed | -$44K | – | 4263 |
|
2019
Q4 | $44K | Buy |
+8,772
| New | +$44K | ﹤0.01% | 1429 |
|
2019
Q3 | – | Sell |
-4,821
| Closed | -$56K | – | 4703 |
|
2019
Q2 | $56K | Buy |
+4,821
| New | +$56K | ﹤0.01% | 1526 |
|